Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd., commonly referred to as Chia Tai-Tianqing, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Jiangsu, China. Established in 1994, the company has made significant strides in developing innovative pharmaceutical products, focusing on areas such as oncology, cardiovascular health, and infectious diseases.
With a robust portfolio that includes both generic and proprietary medications, Chia Tai-Tianqing is recognised for its commitment to quality and research-driven solutions. The company has achieved notable milestones, including various certifications and partnerships that enhance its market position. As a leader in the pharmaceutical sector, Chia Tai-Tianqing continues to expand its operational footprint, contributing to healthcare advancements both domestically and internationally.
-18 vs industry average
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd’s score of 20 is lower than 27% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
Scope 3 accounts for ••• of total emissions.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd's reported carbon emissions
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd, a pharmaceutical preparation manufacturer based in CN, reported a total of approximately 189.5 million kg CO2e in 2019. This figure represents their total carbon emissions for that year. Prior to this, in 2018, the company's total emissions were approximately 120.4 million kg CO2e. While specific reduction targets for Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd are not detailed, the company's emissions data is cascaded from its parent organisation, Sino Biopharmaceutical Limited, which is the source for their CDP disclosures. No explicit company-wide climate commitments or SBTi-aligned reduction targets for Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd are available in the provided information. The company's focus on greenhouse gas emission intensity, as indicated by a value of 9.0e-06 per unit of revenue in 2019, suggests an awareness of environmental impact within its operations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
Inherited from Sino Biopharmaceutical LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project